Insulet's Quarterly Earnings Preview: What You Need to Know Insulet will release its third-quarter earnings next week, and analysts anticipate a double-digit bottom-line growth. Barchart · Oct 27
Insulet Corporation Stock: Is PODD Underperforming the Healthcare Sector? Insulet Corporation has underperformed the healthcare sector over the past year. However, analysts remain strongly bullish about its prospects. Barchart · Jun 19
Are Wall Street Analysts Bullish on Insulet Stock? Although Insulet has lagged the broader market over the past year, Wall Street analysts remain strongly optimistic about the company’s long-term growth prospects. Barchart · May 25
Is Insulet Stock Underperforming the Dow? Insulet has underperformed the Dow recently, yet analysts remain highly optimistic about the stock’s prospects. Barchart · Mar 21
What Are Wall Street Analysts' Target Price for Insulet Stock? Insulet has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects. Barchart · Feb 18
What You Need To Know Ahead of Insulet’s Earnings Release Here’s what analysts are expecting from the underperforming stock Insulet prior to its Q4 earnings. Barchart · Jan 22
Is Insulet Stock Underperforming the Nasdaq? Although Insulet has underperformed the Nasdaq recently, analysts remain highly optimistic about the stock’s prospects. Barchart · Dec 16, 2025
Insulet Stock: Is Wall Street Bullish or Bearish? Insulet has outperformed the broader market over the past year, and analysts remain strongly bullish on the company’s trajectory. Barchart · Nov 20, 2025
Is Insulet Stock Outperforming the S&P 500? Insulet has outperformed the S&P 500 over the past year, and analysts are highly optimistic about the stock’s prospects. Barchart · Sep 24, 2025
Insulet Stock: Analyst Estimates & Ratings Insulet has significantly outpaced the broader market over the past year, and analysts remain very bullish on the stock’s prospects. Barchart · Aug 26, 2025
Cisco, Rocket Companies, Insulet And More On CNBC's 'Final Trades' On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said he remains long on Rocket Companies, Inc. (NYSE:RKT). Benzinga · Aug 20, 2025
Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5 Insulet Corporation (NASDAQ:PODD) reported second-quarter adjusted earnings of $1.17 per share, beating the consensus of 92 cents. Benzinga · Aug 7, 2025
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects. Barchart · Jun 24, 2025
3 Medical Technology Stocks Outperforming in 2025 Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns. MarketBeat · Jun 9, 2025
Barchart · May 23, 2025 Do Wall Street Analysts Like Insulet Stock? Insulet has significantly outpaced the broader market over the past year, and analysts remain bullish on the stock’s prospects.
MarketBeat · May 14, 2025 Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.
Barchart · Apr 28, 2025 Here's What to Expect From Insulet's Next Earnings Report Insulet is set to release its first-quarter results next month, and analysts expect a double-digit earnings growth.
Barchart · Apr 1, 2025 Insulet Stock: Is PODD Outperforming the Healthcare Sector? As Insulet has outperformed relative to the healthcare sector over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Barchart · Feb 25, 2025 Insulet Stock Outlook: Is Wall Street Bullish or Bearish? Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
Barchart · Jan 27, 2025 Earnings Preview: What to Expect From Insulet's Report Insulet is scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit decline.
Barchart · Dec 27, 2024 Is Insulet Stock Outperforming the Dow? Insulet has outperformed the Dow recently, and analysts remain strongly optimistic about the stock’s prospects.
Barchart · Nov 27, 2024 Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink? As Insulet outperformed relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.
International Business Times · Nov 19, 2024 Dexcom Glucose Data To Be Integrated With ŌURA Rings Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help improve consumers' metabolic health.
The Conversation · Oct 16, 2024 Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately 18,000 people who currently live with type 1 diabetes in Aotearoa New Zealand is good news.
Barchart · Sep 24, 2024 Is Insulet Stock Outperforming the Nasdaq? Insulet has outperformed the Nasdaq Composite over the past year and analysts remain strongly bullish about the stock’s prospects.